Heparin‐induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays
- 1 December 2010
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 33 (3) , 245-250
Abstract
Summary: Background: Heparin‐induced thrombocytopenia (HIT) is a rare complication of heparin therapy resulting from antibody production to platelet factor 4 and heparin complexes (H‐PF4).Methods: We have evaluated four enzyme‐linked immunosorbent assay (ELISA)‐based screening tests to identify the best assay(s) with the highest specificity but without underdiagnosis of HIT. As functional assays are difficult to perform, ELISAs are useful to provide clinicians with a timely answer. Over a 10‐month period, all samples (N = 107) referred to our laboratory were tested for HIT antibodies using four commercially available ELISA kits, two detecting IgG/A/M anti‐H‐PF4 antibodies and the other two IgG specific.Results: Twenty‐eight samples were positive by at least one assay; IgGAM ELISAs were found to be more sensitive with 24 samples positive by Asserachrom IgGAM and 23 by Zymutest IgGAM. Only 18 samples were positive by GTI‐PF4‐IgG and Zymutest IgG. The gold standard serotonin release assay (SRA) was used as a confirmation assay, and 11/28 samples tested positive. All these SRA‐positive samples were positive by all four assays. None of the IgGAM‐only‐positive samples was found to be positive by SRA suggesting a better specificity for the IgG‐only assays.Conclusion: Our data strongly support the use of IgG‐only assays for the detection of HIT antibodies.Keywords
This publication has 19 references indexed in Scilit:
- Effectiveness of a new immuno-assay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodiesThrombosis and Haemostasis, 2010
- Variability of anti‐PF4/heparin antibody results obtained by the rapid testing system ID‐H/PF4‐PaGIAJournal of Thrombosis and Haemostasis, 2009
- False‐positive tests for heparin‐induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosusJournal of Thrombosis and Haemostasis, 2009
- The temporal profile of the anti-PF4/heparin immune responseBlood, 2009
- Formation of anti–platelet factor 4/heparin antibodies after cardiac surgery: Influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen statusThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Timely diagnosis and management of heparin‐induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T’s score and particle gel immunoassayBritish Journal of Haematology, 2008
- Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassaysJournal of Thrombosis and Haemostasis, 2008
- Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopeniaThrombosis and Haemostasis, 2008
- Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparinBritish Journal of Haematology, 2002
- Heparin‐induced thrombocytopeniaAustralian and New Zealand Journal of Medicine, 1992